National Research Co. (NASDAQ:NRC - Get Free Report) declared a quarterly dividend on Friday, October 25th,Zacks Dividends reports. Investors of record on Friday, December 27th will be paid a dividend of 0.12 per share on Friday, January 10th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date of this dividend is Friday, December 27th.
National Research has increased its dividend by an average of 31.7% per year over the last three years.
National Research Price Performance
Shares of NASDAQ NRC traded down $0.08 during trading hours on Wednesday, hitting $17.76. 50,567 shares of the stock were exchanged, compared to its average volume of 88,574. The company's fifty day simple moving average is $18.88 and its two-hundred day simple moving average is $21.28. The company has a market cap of $416.93 million, a PE ratio of 15.72 and a beta of 0.52. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research has a 1-year low of $16.74 and a 1-year high of $42.18.
National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Friday, October 25th. The company reported $0.24 earnings per share for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The business had revenue of $35.82 million during the quarter.
About National Research
(
Get Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Featured Articles
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.